Milestone Scientific Inc. (MLSS)

Milestone Scientific Balance Sheet

Financials in millions USD. Fiscal year is January - December.

Year	2023	2022	2021	2020	2019
Cash & Equivalents	2.98	8.72	14.76	14.22	1.52
Short-Term Investments	2.98	0	0	0	0
Cash & Cash Equivalents	5.95	8.72	14.76	14.22	1.52
Cash Growth	-31.68%	-40.97%	3.80%	838.08%	103.96%
Receivables	0.31	0.69	0.94	1.08	1.71
Inventory	2.64	1.79	1.54	2.42	1.62
Other Current Assets	1.89	1.77	1.68	0.83	1.23
Total Current Assets	10.79	12.97	18.93	18.55	6.08
Property, Plant & Equipment	0.37	0.48	0.57	0.66	0.06
Goodwill and Intangibles	0.18	0.23	0.28	0.33	0.38
Other Long-Term Assets	0.02	0.02	0.02	0.02	0.04
Total Long-Term Assets	0.58	0.73	0.88	1.02	0.48
Total Assets	11.37	13.7	19.81	19.57	6.56
Accounts Payable	1.1	1.91	1.18	0.87	2.74
Deferred Revenue	0	0	0	0.24	0.34
Current Debt	0.11	0.1	0.09	0.36	0.02
Other Current Liabilities	1.86	1.29	1.83	1.41	1.83
Total Current Liabilities	3.08	3.3	3.1	2.88	4.93
Long-Term Debt	0.28	0.4	0.5	0.59	0
Total Long-Term Liabilities	0.28	0.4	0.5	0.59	0
Total Liabilities	3.36	3.7	3.59	3.46	4.93
Total Debt	0.4	0.5	0.59	0.94	0.02
Debt Growth	-20.33%	-15.27%	-37.77%	5799.70%	-
Retained Earnings	-123.34	-116.41	-107.7	-100.89	-93.52
Shareholders' Equity	8.01	10.23	16.37	16.2	1.7
Net Cash / Debt	5.56	8.22	14.18	13.28	1.5
Net Cash / Debt Growth	-32.37%	-42.03%	6.75%	785.25%	101.81%
Net Cash Per Share	0.08	0.12	0.21	0.21	0.03
Working Capital	7.72	9.67	15.84	15.68	1.15
Book Value Per Share	0.11	0.14	0.24	0.26	0.04

Source: Financials are provided by Nasdaq Data Link and sourced from the audited annual (10-K) and quarterly (10-Q) reports submitted to the Securities and Exchange Commission (SEC).